Authored and contributed to PharmaLeaders by Jason Bhan, MD Accurate analysis of healthcare data is critical for research, delivery of care, treatment variability, and improving patient outcomes. The ability to identify patterns in real-world data (RWD) demands insights with faster speeds, greater specificity, and improved accuracy. And the challenges are increasing as more … [Read more...]
The Roadmap to Real-Time Data Sharing in Clinical Trials
Article authored and contributed to PharmaLeaders by Marc Leighton, VP of Product for Florence Healthcare With the rise of decentralized technology across the clinical trial industry, real-time data sharing has become critical. If research sites, local physicians, trial participants, CROs, and sponsors can’t instantly share data with one another, remote or hybrid clinical … [Read more...]
How Training Simulations Will Help Pharma Sales Teams in the Post-Pandemic Market
Article contributed to PharmaLeaders and authored by: Jeremy Lovelace, founder and director of HFX Training. Across all industries, sales teams face an uncertain future, and pharma is no different. Many key sales practices, such as healthcare provider meetings and terrority-focused engagement have been replaced by the unfamiliar environment of zoom calls, … [Read more...]
Healthcare M&A on the Rise: 5 Principles for Creating a New Brand that Resonates
Article contributed to PharmaLeaders by Matt Egan, Executive Director, Strategy at Siegel+Gale A wave of M&A deals is coming to the healthcare industry. According to consulting firm BDO, 44% of healthcare CFOs are expecting to drive an increase in partnerships across the healthcare ecosystem and 42% are predicting further consolidation. The pandemic accelerated digital … [Read more...]
Patient-Centered Approaches to Clinical Research in Oncology
Article contributed to PharmaLeaders by Edward F. Ikeguchi, M.D., the Chief Executive Officer at AiCure Most of us have personal experiences with cancer, whether ourselves or with loved ones. We know that cancer is frightening and that treatment regimens can be stressful, exhausting and overwhelming. Patients participating in drug trials for oncology are subject to a list of … [Read more...]